Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

The technology sector is no longer asking what artificial intelligence can do for us. It is asking what AI can do for itself.

OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...

You can bring initial model predictions closer to reality by training those AI models on rich patient data. The more detailed ...

SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal ...

Amazon has reportedly developed an artificial intelligence platform called Bio Discovery, designed to help drug researchers ...

QClaw 's international beta opened with a number that sounds like footnote material until you think about what it implies: 99 ...

Three Vectors of Urban Transformation,” published in Applied Sciences, explores how cities are entering a new phase of technological evolution driven by the convergence of agentic artificial ...

The model will be available initially as a research preview to some of the company’s business customers, OpenAI said ...

Meta's new hyperagent framework breaks the AI "maintenance wall," allowing systems to autonomously rewrite their own logic ...